Literature DB >> 28641364

Access to Coverage and Care for People with Preexisting Conditions: How Has it Changed Under the ACA?

Sherry Glied1, Adlan Jackson1.   

Abstract

ISSUE: Prior to the Affordable Care Act (ACA), people with preexisting health conditions could be denied insurance coverage or charged higher rates. If the law is repealed, these protections could be diluted or lost altogether. GOALS: Assess the ACA's impact on coverage and access for people with preexisting conditions and compare their coverage gains with state high-risk-pool enrollment pre-ACA.
METHODS: Analysis of Behavioral Risk Factor Surveillance System data for the period 2011–13 to 2015. KEY FINDINGS AND
CONCLUSIONS: Between 2013 and 2015, 16.5 million nonelderly adults gained coverage following full ACA implementation. Of those, 2.6 million had preexisting conditions that could have otherwise precluded them from coverage because of discriminatory denials and pricing; 9.4 million had conditions that could have otherwise affected insurance cost. We found strong correlations between these coverage gains and access to care. Coverage and access gains for people with preexisting conditions were unrelated to the size or existence of the state high-risk pools that 35 states funded for such individuals pre-ACA. Our findings suggest that proposals to replace current protections for people with preexisting conditions with high-risk pools are unlikely to be sufficient to maintain the ACA's gains.

Entities:  

Mesh:

Year:  2017        PMID: 28641364

Source DB:  PubMed          Journal:  Issue Brief (Commonw Fund)        ISSN: 1558-6847


  2 in total

1.  Editor's Spotlight/Take 5: The Affordable Care Act Decreased the Proportion of Uninsured Patients in a Safety Net Orthopaedic Clinic.

Authors:  Paul A Manner
Journal:  Clin Orthop Relat Res       Date:  2018-05       Impact factor: 4.176

2.  Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?

Authors:  Azeem Tariq Malik; John Alexander; Safdar N Khan; Thomas J Scharschmidt
Journal:  Clin Orthop Relat Res       Date:  2021-03-01       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.